Yutaka Niihara, Chairman and CEO, 10% Owner at Emmaus Life Sciences, Inc. (EMMA), bought 9,500 shares at $1.54 ($15K) on 2021-12-16, disclosed to the SEC on 2021-12-17.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.57 | 1,000 | $2K | 10.8% |
| 2 | $1.52 | 1,500 | $2K | 15.6% |
| 3 | $1.52 | 3,000 | $5K | 31.3% |
| 4 | $1.54 | 4,000 | $6K | 42.3% |
| Total | $1.53 avg | 9,500 | $15K | 100% |
| Filing → |
| EMMA | BUY | 2022-10-31 | $19K | — | Filing → |
| EMMA | BUY | 2022-10-24 | $11K | — | Filing → |
| EMMA | BUY | 2022-10-19 | $9K | — | Filing → |